Learn more about the Centre for Doctoral Training in Transformative Pharmaceutical Technologies.
The CDT is a partnership between the University of Nottingham, University College London (UCL), and the SSPC, the Science Foundation Ireland Research Centre for Pharmaceuticals in Ireland. It builds on our highly successful previous CDTs in Targeted Therapeutics and Advanced Therapeutics & Nanomedicines.
Applications for 2021/2022 have now closed. Applications for 2022/23 will open in November/December 2021.
To apply you will need to complete an online application form, which includes statements on your motivations for applying to the CDT and how your previous skills and experience have prepared you for a PhD in this research area.
Our panel of academics will consider all applications and those successful at the application stage will be shortlisted for an interview.
All communications, such as invites to interview and outcomes of your application, will be sent via email. We aim to communicate decisions as soon as possible, but please bear in mind that we receive a high volume of applications and processing these can take some time.
In the meantime if you would like to learn more about the Centre please view our recent Virtual Open Day by clicking on the following Blackboard Collaborate link. This was a student-led event which included a welcome from our Directors, Prof Snow Stolnik from University of Nottingham and Dr Anne-Marie Healy from Trinity College Dublin and presentations from our current students. We would like to thank our CDT Equality, Diversity & Inclusion Working Group for making this event possible and to our students for all their hard work.
Additional information and enquiries
For a full summary of our Doctoral Training Programme please visit the official CDT in Transformative Pharmaceutical Technologies website.
If you have any enquiries about the CDT programme, please contact: